•
Jun 30, 2019

Bio-Rad Q2 2019 Earnings Report

Total Revenue
$573M
Previous year: $576M
-0.6%
EPS
$1.57
Previous year: $1.64
-4.3%
Gross Margin
53.7%
Operating Margin
9.8%
Gross Profit
$308M
Previous year: $302M
+2.0%
Cash and Equivalents
$581M
Previous year: $403M
+44.1%
Free Cash Flow
$133M
Previous year: $51.1M
+160.4%
Total Assets
$7.65B
Previous year: $6.39B
+19.7%

Bio-Rad

Bio-Rad

Bio-Rad Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income